MedPage Today1d
Mold and Parkinson's? Cannabis and Brain Function; Women and Long COVID Risk
The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
How I Became the First Person With Parkinson's to Row Across the Pacific
A few years after Patrick Morrissey, 53, learned he had early onset Parkinson's disease, a group of friends came to him with ...
Can mold exposure cause Parkinson’s disease? Colorado Springs family hopes to prove “landmark” legal case
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...
Northern Virginia Daily20h
Exercise class helps Parkinson's patients manage their symptoms
Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...
fox17online9h
Fighting Back: Rock Steady Boxing West Michigan helps Parkinson's patients regain control
At Rock Steady Boxing West Michigan, patients are using boxing as a form of therapy to combat the effects of Parkinson's.
TMJ419h
How boxing helps those with Parkinson's fight back against the disease in West Bend
WEST BEND, Wis. — Rock Steady Boxing participants live with a form of Parkinson's disease and want to raise awareness and ...
A ‘Ninja Warrior’ opens up about living with Parkinson’s disease
In the end, I have to be my best advocate for my own care. It took years, but when I became my best advocate, serious change happened,” Choi says.
News Medical on MSN1d
Artificial intelligence model identifies potential risk genes for Parkinson’s disease
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
devdiscourse3d
Targeted Nano Formulation for Sustained Release of 17β-Estradiol Shows Promise in Parkinson's Disease Therapy
In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...
Inhibikase Therapeutics stops Parkinson's drug development as it fails to show benefits in study
Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...